Blue dye could make thyroid cancer surgery safer and more precise
NCT ID NCT07354698
First seen Jan 22, 2026 · Last updated May 22, 2026 · Updated 20 times
Summary
This study tests whether injecting a blue dye (mitoxantrone) into the thyroid during robotic surgery helps surgeons find and remove cancer-containing lymph nodes while protecting the parathyroid glands. About 114 people with papillary thyroid cancer will be randomly assigned to get the dye or not. The goal is to see if the dye leads to fewer accidental parathyroid removals and better lymph node clearance.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PAPILLARY THYROID CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Daping Hospital
Chongqicun, 400042, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.